Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.